Robb Lawrence

In 2020, Robb Lawrence joined Camargo Pharmaceutical Services as Vice President of Commercial Strategy with responsibility for Camargo’s expanding suite of commercial strategy solutions.

Prior to joining Camargo, Lawrence spent 10 years as a health care entrepreneur, building companies designed to bring new and innovative pharmaceutical products to the US market. He founded and served as CEO of two virtual specialty pharmaceutical companies, TLC Therapeutics and Tropical Disease Therapeutics (TDT), both of which were created to execute on co-development partnerships with larger global pharma companies. Prior to founding TLC and TDT, Lawrence launched and managed the day-to-day operations of Salient Consulting, a boutique strategy consulting practice focused on strategic product development and go-to-market strategies for novel medicines.

Prior to his entrepreneurial endeavors, Lawrence held numerous positions at Merck and Company and played a key role on the marketing team responsible for launching Merck’s Diabetes Franchise (Januvia® and Janumet®).

Lawrence earned a Master of Business Administration with a focus in Health Sector Management from Duke University’s Fuqua School of Business and a Bachelor of Arts in Literature and History from Wake Forest University. He lives outside Baltimore, Maryland, with his wife and four children.